D. E. Shaw & Co., Inc. Harmony Biosciences Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 310,004 shares of HRMY stock, worth $12.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

310,004

Previous 279,435 10.94%

Holding current value

$12.4 Million

Previous $9.38 Million 0.33%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $880,692 - $1.01 Million	30,569 Added 10.94%	310,004 $9.35 Million
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $69,467 - $81,374	-2,321 Reduced 0.82%	279,435 $9.38 Million
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $267,705 - $470,994	13,943 Added 5.21%	281,756 $9.1 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $872,255 - $1.07 Million	27,352 Added 11.37%	267,813 $8.78 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $1.4 Million - $1.72 Million	45,975 Added 23.64%	240,461 $8.46 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $908,138 - $1.59 Million	-29,485 Reduced 13.16%	194,486 $6.35 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $8.07 Million - $10.8 Million	177,772 Added 384.8%	223,971 $12.3 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $396,331 - $522,505	9,423 Added 25.62%	46,199 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $278,952 - $433,731	8,317 Added 29.22%	36,776 $1.79 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $943,131 - $1.46 Million	28,459 New	28,459 $1.39 Million
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $1.15 Million - $1.73 Million	-44,765 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $1.16 Million - $1.5 Million	44,765 New	44,765 $1.26 Million

Others Institutions Holding HRMY

# of Institutions

228

Shares Held

45.4M

Call Options Held

48.2K

Put Options Held

61.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.36B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account